Literature DB >> 7983963

Three cases of hepatocellular carcinoma among cyproterone users. Ad hoc Committee on Androcur Users.

S Watanabe, S Yamasaki, A Tanae, I Hibi, T Honna.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7983963     DOI： 10.1016/s0140-6736(94)90373-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  Prostate cancer: a comprehensive review.

Authors:  S N Pentyala; J Lee; K Hsieh; W C Waltzer; A Trocchia; L Musacchia; M J Rebecchi; S A Khan
Journal:  Med Oncol       Date:  2000-05       Impact factor: 3.064

Review 2.  Patient-Clinician choice in palliation of metastatic prostate cancer.

Authors:  A V Kaisary
Journal:  Drugs Aging       Date:  2000-11       Impact factor: 3.923

Review 3.  Cyproterone acetate: is it hepato- or genotoxic?

Authors:  T Rabe; K Feldmann; L Heinemann; B Runnebaum
Journal:  Drug Saf       Date:  1996-01       Impact factor: 5.606

Review 4.  Hepatotoxicity induced by cyproterone acetate: a report of three cases.

Authors:  Ioanna Savidou; Melanie Deutsch; Aspasia S Soultati; Dimitrios Koudouras; Georgia Kafiri; Spyridon P Dourakis
Journal:  World J Gastroenterol       Date:  2006-12-14       Impact factor: 5.742

5.  Controversies in the management of advanced prostate cancer.

Authors:  C J Tyrrell
Journal:  Br J Cancer       Date:  1999-01       Impact factor: 7.640

6.  Occurrence of cancer in women with Turner syndrome.

Authors:  H Hasle; J H Olsen; J Nielsen; J Hansen; U Friedrich; N Tommerup
Journal:  Br J Cancer       Date:  1996-05       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.